|
|
||||||||
|
FJ
EXPRESS SUMMARY ARTICLE The Full-length version of this article is also available, published online December 4, 2003 as doi:10.1096/fj.03-0316fje. |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
INSERM U456, Détoxication et Réparation Tissulaire, Faculté de Pharmacie, Université Rennes 1, 35043 Rennes Cedex, France
2Correspondence: INSERM U456, Faculté de Pharmacie, Université Rennes 1, 2, avenue du Professeur Léon Bernard, 35043 Rennes cedex, France. E-mail: Dominique.Lagadic{at}rennes.inserm.fr
SPECIFIC AIMS
The aim of this study was to examine the effects of polycyclic aromatic hydrocarbons (PAHs), more specifically benzo(a)pyrene B(a)P, on intracellular pH (pHi) in liver epithelial cells. Indeed, these ubiquitous environmental pollutants to which humans are commonly exposed elicit numerous important cellular effects, such as carcinogenic and apoptotic effects, also known to be affected by or to affect cellular H+ concentrations, notably through Na+/H+ exchanger 1 (NHE1) modulation.
PRINCIPAL FINDINGS
1. PAHs induce an early intracellular alkalinization due to NHE1 activation followed by a late acidification
The effects of B(a)P on pHi were tested in rat liver F258 epithelial cell line using carboxy-SNARF-1 as pH-sensitive fluorophore and microspectrofluorimetry. B(a)P, tested at two concentrations (5 µM and 50 nM), induced an early transient alkalinization, followed by a late acidification. Such variations were detected in HEPES and in CO2-/HCO3- medium. However, at 5 µM, the time course of pHi changes appeared to be faster than those at 50 nM. Determinations of pHi recovery after an acid load showed an increase of acid efflux concomitantly to alkalinization. By using cariporide, we demonstrated that NHE1 was activated upon B(a)P treatment and was necessary for biphasic pHi changes to occur (Fig. 1
).
|
2. CYP1A1-related metabolism of B(a)P is responsible for NHE1 activation through increased production of H2O2
The role for CYP1A1-related metabolism in B(a)P-induced pHi changes was evaluated using
-naphtoflavone (
-NF), a known CYP1A1 inhibitor. This compound prevented any pHi variation induced by B(a)P; dioxin, a specific ligand of the aryl hydrocarbon receptor, remained ineffective on pHi. Dimethyl benzanthracene (DMBA), whose metabolism is known to produce reactive metabolites, was found to induce biphasic pHi-changes. During the course of our experiments to evaluate the level of regulation of NHE1 by B(a)P, we found that the affinity of the exchanger toward H+ was increased with no change in either Vmax or protein expression. A role for reactive oxygen species (ROS), which we showed to be produced during CYP1A1 metabolism of B(a)P, was next tested. We found that the antioxidant molecule thiourea prevented both H2O2 production and NHE1 activation.
3. NHE-1-related transient alkalinization is involved in B(a)P-induced apoptosis of liver epithelial cells
B(a)P-induced apoptosis, as estimated by Hoechst 33342 nuclei staining and caspase activity (estimated by cleavage of the substrate DEVD-AMC), was found to be prevented by
-NF and bongkrekic acid (BgA), an inhibitor of mitochondria-dependent apoptosis. Concerning pHi, BgA was shown to inhibit only the late acidification, indicating that mitochondria were involved in this pHi change. Apoptosis was significantly reduced by cariporide added before the development of alkalinization (Fig. 2
). Moreover, we found that DMBA induced a cariporide-sensitive apoptosis whereas dioxin and benzanthracene were without any toxic effects in F258 cells.
|
CONCLUSIONS AND SIGNIFICANCE
This study is the first to identify intracellular H+ homeostasis as a new target for these compounds. Indeed, isoform 1 of the Na+/H+ exchanger was shown to be transiently activated by PAHs, likely via an increase of its affinity to H+. Whereas aryl hydrocarbon receptor was not directly involved, we found that NHE1 protein activation was triggered by the H2O2 production resulting from CYP1A1-dependent metabolism, illustrating the importance of ROS production in mediating some PAH effects. Another important finding was that this transient alkalinization was necessary for PAHs to induce apoptosis shown to be associated with a secondary, mitochondria-dependent intracellular acidification (Fig. 3
). In support of this, we demonstrated that only PAHs (such as DMBA) capable of eliciting biphasic pHi changes induced apoptotic effects. The precise targets of intracellular alkalinization in the apoptotic cascade remain to be elucidated. Our study points to NHE1 transient activation as a possible important early signal in the development of the apoptotic cascade induced by toxic xenobiotics such as PAHs.
|
FOOTNOTES
1 To read the full text of this article, go to http://www.fasebj.org/cgi/doi/10.1096/fj.03-0316fje ![]()
This article has been cited by other articles:
![]() |
S. J. Weintraub and B. E. Deverman Chronoregulation by Asparagine Deamidation Sci. Signal., October 23, 2007; 2007(409): re7 - re7. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rebillard, X. Tekpli, O. Meurette, O. Sergent, G. LeMoigne-Muller, L. Vernhet, M. Gorria, M. Chevanne, M. Christmann, B. Kaina, et al. Cisplatin-Induced Apoptosis Involves Membrane Fluidification via Inhibition of NHE1 in Human Colon Cancer Cells Cancer Res., August 15, 2007; 67(16): 7865 - 7874. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Huc, X. Tekpli, J. A. Holme, M. Rissel, A. Solhaug, C. Gardyn, G. Le Moigne, M. Gorria, M.-T. Dimanche-Boitrel, and D. Lagadic-Gossmann c-Jun NH2-Terminal Kinase-Related Na+/H+ Exchanger Isoform 1 Activation Controls Hexokinase II Expression in Benzo(a)Pyrene-Induced Apoptosis Cancer Res., February 15, 2007; 67(4): 1696 - 1705. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lemarie, C. Morzadec, D. Merino, O. Micheau, O. Fardel, and L. Vernhet Arsenic Trioxide Induces Apoptosis of Human Monocytes during Macrophagic Differentiation through Nuclear Factor-{kappa}B-Related Survival Pathway Down-Regulation J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 304 - 314. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |